AlensiaXR — SEC Form D Filing
AlensiaXR filed an SEC Form D on January 8, 2026, reporting $2.12M raised in EdTech.
Form D filing details
- Filing
- SEC Form D
- Filing date
- January 8, 2026
- Amount reported
- $2.12M
- Round stage
- Seed
- Industry
- EdTech
- Headquarters
- Cleveland, OH, USA
- Website
- https://www.alensiaxr.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Traditional methods for teaching anatomy, neuroanatomy, and health sciences are often expensive, time-consuming, and can lead to lower retention rates for complex concepts.
Solution
AlensiaXR provides immersive 3D anatomy software using extended reality (XR) technology, enabling healthcare students to learn complex anatomical structures faster, retain information longer, and engage more deeply with the material.
Verdict
This cleared because it presented a clear cost-saving and efficiency play, not because it promised novel educational outcomes. Investors were implicitly betting on predictable B2B university procurement cycles and the immediate, albeit niche, utility of XR over traditional methods. The upside was limited by the relatively small addressable market within higher education and the risk of being a feature, not a platform, for broader educational transformation.
Source: SEC EDGAR Form D filing